InSights Hub

Miscellaneous

Showing 91 to 100 of 360 (Page 10)

Guidelines Spotlight Advancing Genetic Testing in Kidney Diseases

Advancing Genetic Testing in Kidney Diseases – Guidelines Spotlight

In the United States, 37 million people suffer from chronic kidney disease, with 10% of adults and 70% of children affected by genetic causes. Despite advancements in genetic testing and a growing understanding of the genetic factors contributing to kidney diseases, genetic testing in nephrology lags behind other medical specialties. To address this gap, we […]

Read More
ASA 2024 Conference Recap - Pain Management & Anesthesia

Pain-Focused Sessions at ANESTHESIOLOGY 2024 – Conference Recap

The American Society of Anesthesiologists (ASA) recently hosted their annual meeting, ANESTHESIOLOGY 2024 (ANES), in Philadelphia, PA from October 18-22nd. This prestigious event offered attendees a unique opportunity to delve into cutting-edge ideas and innovations, achieve professional goals, and expand their network within the field of anesthesiology. ASA stands as a strong advocate for patients […]

Read More
Guideline Timeline - AHAASA Primary Stroke Prevention

AHA/ASA’s Primary Stroke Prevention 2024 vs 2014 – Guidelines Timeline

In this edition of our Guidelines Timeline series, we will explore the recently released 2024 Guideline for the Primary Prevention of Stroke by the American Heart Association (AHA) and American Stroke Association (ASA). This updated guideline supersedes the previous version from 2014, providing clinicians with a comprehensive resource to aid in the implementation of prevention […]

Read More

USPSTF Announces Breastfeeding Recommendation Statement is Now Open for Public Comment

The United States Preventive Services Task Force (USPSTF) has recently released their draft recommendation statement on breastfeeding interventions. The statement, titled “Breastfeeding: Behavioral Counseling Interventions,” was published online on October 22, 2024. According to the latest screening guidelines, the USPSTF recommends providing or referring pregnant and postpartum individuals to interventions that support breastfeeding. These recommendations […]

Read More
AACAP 2024 Conference Recap - Attention Deficit Hyperactivity Disorder (ADHD)

AACAP 2024 – Conference Recap on ADHD

The American Academy of Child and Adolescent Psychiatry (AACAP) Annual Meeting was held in Seattle, Washington from October 14-19, 2024. This prestigious event serves as the largest gathering of child and adolescent psychiatrists globally, providing a valuable opportunity to engage with and learn from peers and colleagues from over 60 countries. The AACAP 2024 Annual […]

Read More
Guidelines Rundown - Audiology Hearing Loss

Audiology / Hearing Loss – Guidelines Rundown (National Audiology Awareness Month 2024)

In honor of National Audiology Awareness Month 2024, our Guidelines Rundown Series will focus on the audiology/hearing loss related guidelines. Multiple societies have released comprehensive guidelines to provide guidance and support for clinical decision-making in the evaluation, diagnosis, and management of hearing loss in both adults and children. In this article, we will offer an […]

Read More

Vedolizumab (Entyvio/Takeda) – Guidelines+ Monographs

Welcome to the latest installment of our Guidelines+ Monographs Series. In this edition, we will delve into the medication vedolizumab, marketed under the brand name Entyvio by Takeda Pharmaceuticals. Entyvio is an integrin receptor antagonist indicated in adults for the treatment of moderately to severely active ulcerative colitis (UC) and moderately to severely active Crohn’s […]

Read More
Guidelines + Trials Rundown Urinary Tract Infection (UTI)

Urinary Tract Infection (UTI) in Adults – Guidelines+ Trials Rundown

Today, we will be looking into the latest research and clinical trials focused on both uncomplicated and complicated urinary tract infections (UTIs) in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for UTI, specifically targeting adults in the United States. Please note that the dates provided are approximate […]

Read More

Aripiprazole (Abilify Asimtufii/Otsuka) – Guidelines+ Monographs

Welcome to the latest edition of our Guidelines+ Monographs Series. In this installment, we will delve into the medication aripiprazole, marketed under the brand name Abilify Asimtufii by Otsuka Pharmaceutical Co., Ltd. Abilify Asimtufii (aripiprazole) is a long-acting injectable atypical antipsychotic for the treatment of schizophrenia and bipolar I disorder. It was initially approved in […]

Read More
Healthcare News & Research - October 2024

Healthcare News & Research – October 2024

Welcome to our succinct summaries of the most recent healthcare news and research. Keep yourself informed with our easily digestible updates sourced from medical media and news outlets. Life Expectancy and Geographic Variation in Mortality: An Observational Comparison Study of Six High-Income Anglophone Countries Study Details | Source Upper Gastrointestinal Mucosal Damage and Subsequent Risk […]

Read More
« Back to InSights Hub